Voyageur Pharmaceuticals (CVE:VM) Trading Up 47.4% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price rose 47.4% during mid-day trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Performance

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company’s 50 day moving average is C$0.08 and its 200-day moving average is C$0.06.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.